ESTA · Establishment Labs Holdings Inc

-

Please sign in to comment on ESTA

1 Comment

Admin

4 years, 10 months ago

Establishment Labs Holdings Inc is currently in a long term uptrend where the price is trading 53.8% above its 200 day moving average.

From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.2.

Establishment Labs Holdings Inc's total revenue rose by 11.2% to $27M since the same quarter in the previous year.

Its net income has dropped by 1.6% to $-6M since the same quarter in the previous year.

Finally, its free cash flow grew by 142.9% to $2M since the same quarter in the previous year.

Based on the above factors, Establishment Labs Holdings Inc gets an overall score of 4/5.

Exchange	NASDAQ
CurrencyCode	USD
ISIN	VGG312491084
Industry	Medical Devices
Sector	Healthcare

PE Ratio	None
Target Price	83.25
Beta	0.94
Market Cap	2B
Dividend Yield	None

ABOUT

Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

ESTA · Establishment Labs Holdings Inc

-

Establishment Labs Holdings Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Establishment Labs Holdings Inc using a moving average strategy